32 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Akebia Therapeutics, Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Frequent amendments usually mean worksite or role changes; each one must be covered by a new LCA before the change takes effect.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
Median offered wage is 46% above the DOL prevailing wage across 4 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Akebia Therapeutics, Inc. sponsors H-1B workers, with 32 certified LCAs on file (FY2021–FY2026), including 1 in FY2026. The median certified salary is $132,500 (P25 $123,750, P75 $166,837). With a 44% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Akebia Therapeutics, Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 52% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 19 | 0 | 0 | 19 |
| FY2022 | 6 | 0 | 8 | 14 |
| FY2023 | 3 | 0 | 4 | 7 |
| FY2024 | 1 | 0 | 4 | 5 |
| FY2025 | 2 | 0 | 0 | 2 |
| FY2026 | 1 | 0 | 0 | 1 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Senior Specialist, Regulatory Affairs I-200-26104-791286 | $118,431/yr | II | Seattle, WA | Apr 14, 2026 | Certified |
Clinical Pharmacologist I-200-25226-242384 | $141,012/yr | II | Raleigh, NC | Aug 14, 2025 | Certified |
Clinical Pharmacologist I-200-25122-934336 | $141,012/yr | II | Fayetteville, NC | May 02, 2025 | Certified |
Senior Scientist, Analytical Sciences, CMC I-200-24039-702460 | $153,763/yr | IV | Cambridge, MA | Feb 08, 2024 | Certified |
Regulatory Specialist, Regulatory Affairs I-200-23217-241534 | $96,588/yr | II | Seattle, WA | Aug 05, 2023 | Certified |
Senior Oracle Solution Architect I-200-23188-173200 | $178,890/yr | IV | Cambridge, MA | Jul 07, 2023 | Certified |
Principal Scientist (Drug Product) I-200-23172-134063 | $185,166/yr | IV | Somerset, NJ | Jun 21, 2023 | Certified |
Regulatory Specialist, Regulatory Affairs I-200-22152-233268 | $92,873/yr | II | Cambridge, MA | Jun 01, 2022 | Certified |
Clinical Pharmacology Specialist I-200-22152-230433 | $105,994/yr | II | Fayetteville, NC | Jun 01, 2022 | Certified |
Senior Scientist, Analytical Sciences I-200-21343-753639 | $137,000/yr | III | Branchburg, NJ | Dec 09, 2021 | Certified |
Senior, Drug Safety & PV Scientist I-200-21322-712252 | $168,717/yr | II | Cambridge, MA | Nov 17, 2021 | Certified |
Sr. Scientist, Technical Operations I-200-21322-712249 | $125,000/yr | III | Cambridge, MA | Nov 17, 2021 | Certified |
Sr. Oracle Solutions Architect I-200-21322-712251 | $166,837/yr | III | Cambridge, MA | Nov 17, 2021 | Certified |
Scientist II, Analytical Development I-200-21309-690538 | $125,000/yr | III | Parsippany, NJ | Nov 05, 2021 | Certified, withdrawn |
Enterprise Architect I-200-21252-575361 | $114,537/yr | IV | Cambridge, MA | Sep 09, 2021 | Certified |
IT Business Systems Manager I-200-21235-537942 | $150,000/yr | IV | Cambridge, MA | Aug 23, 2021 | Certified |
Manager of Operations, Drug Safety and Pharmacovigilance I-200-21204-479608 | $130,000/yr | I | Cambridge, MA | Jul 23, 2021 | Certified |
Associate Director, Analytical Sciences I-200-21200-471243 | $162,000/yr | II | Cambridge, MA | Jul 19, 2021 | Certified |
Senior Scientist I-200-21175-424419 | $130,000/yr | IV | Cambridge, MA | Jun 24, 2021 | Certified |
Scientist II, Drug Product Development I-200-21152-357953 | $120,000/yr | II | Cambridge, MA | Jun 01, 2021 | Certified |
Sr. Computer System Validation Specialist I-200-21103-220963 | $120,000/yr | III | Cambridge City, MA | Apr 13, 2021 | Certified |
Sr. Oracle Solutions Architect I-200-20322-915657 | $166,837/yr | III | Cambridge, MA | Nov 17, 2020 | Certified |
Scientist II, Analytical Development I-200-20322-915010 | $125,000/yr | II | Cambridge, MA | Nov 16, 2020 | Certified |
Scientist II, Analytical Development I-200-20318-912647 | $125,000/yr | II | Cambridge, MA | Nov 13, 2020 | Certified |
Principal Statistical Programmer I-200-20281-864448 | $135,000/yr | III | Cambridge, MA | Oct 07, 2020 | Certified |
Associate CMC Project Manager I-200-20140-586015 | $81,078/yr | III | Cambridge, MA | May 19, 2020 | Certified, withdrawn |
Associate Director, Regulatory Affairs I-200-19314-137111 | $170,000/yr | II | Cambridge, MA | Nov 09, 2019 | Certified, withdrawn |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Nov and Jun — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
4 states · 8 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →